Aseptic production methods are at the heart of the latest development in pharmaceuticals in key areas such as cell and gene therapies or in the manufacture of particularly potent or toxic product. Existing aseptic production practices are slow and inefficient, and unsuited to modern practices. A state-of-the-art aseptic vial capping and sealing solution delivers complete aseptic containment with increased throughput volume, dramatically improving efficiency of production of these high-value products.
The Steriline RVCM Robotic Vial Capping Machine is a highly advanced aseptic capping solution for today’s cutting-edge pharmaceuticals. It has been specifically engineered for the campaign production of high-value product that requires complete containment.
With a capacity of up to 6,000 pcs/h, the RVCM uses a superb anthropomorphic VHP compatible robot from industry-leaders STÄUBLI to handle all vial transport.
4 capping heads operate simultaneously to provide maximum efficiency while minimising errors. The RVCM has been engineered using a “zero rejection” philosophy. This means that where the machine detects a missing cap or stopper the vial is recapped, not rejected. This reduces wastage of high-value product to near zero.
Throughout the capping process, the RVCM continuously monitors for the presence of viable and non-viable particles. It has been engineered to meet or exceed all relevant cGMP, GAMP and 21CFR Part11 requirements.
As part of a complete aseptic production system the RVCM can be added to the same monobloc as the Steriline RVFM, providing you with a self-contained and complete aseptic vial filling and capping solution.